Insulet EV/EBIT PODD

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2018.

Today, Oct 23, 2026: 20.4×
8-year median: 193×
Against its 8-year history: 3rd; percentile: 0 is its lowest day, 100 its highest
8-year range: 18.1× to 496×
Peer median: 17.6×

Insulet's EV/EBIT is 20.4× as of Oct 23, 2026.

That is below its 8-year median of 193×, lower than on 97% of days in the last 8 years.

Over that time it ranged from 18.1× in Oct 2026 to 496× in Feb 2019.

The median for 10 medical instruments and supplies stocks of a similar size is 17.6×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	20.4×	18.1×	47.1×
2025	47.1×	47.1×	68.3×
2024	62.4×	48.6×	94.2×
2023	99.8×	69.0×	278×
2022	209×	98.0×	256×
2021	272×	228×	383×
2020	219×	190×	285×
2019	226×	171×	496×
2018	468×	445×	492×

Against its peers

Companies in Medical - Instruments & Supplies nearest Insulet's size, closest first, today.

Company	EV/EBIT
PODDInsulet	20.4×
GMEDGlobus Medical	16.3×
ALGNAlign Technology	16.2×
COOCooper Companies	17.2×
PENPenumbra	65.8×
SOLVSolventum	8.4×
MSAMSA Safety	18.0×
MMSIMerit Medical Systems	28.6×
HAEHaemonetics	26.8×
VNTVontier	10.9×
BMIBadger Meter	26.2×
Peer median	17.6×

Where Insulet ranks

#20of 46Medical instruments and supplies stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Insulet

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.